HIL Applied Medical
A Consortium led by HIL wins major R&D grant by European Union The European Commission managing Horizon 2020 – the EU Framework Program for Research and Innovation – today announced its decision to fully fund a proposal by HIL and its …
Continue reading »Dr. Ehud (Udi) Netzer is named Chairmen at HIL. Dr. Netzer joined HIL’s Board of Directors last year and was today appointed by HIL’s Board of Directors as Chairman. In recent months he was intimately involved with Israel’s response to the COVID-19 epidemic, …
Continue reading »We’re on the Map! HIL featured in The Marker Magazine STARTUP NATION HIGH-TECH MAP: The Marker magazine tells the story of HIL Applied Medical and its unique Proton Therapy solution within the startup nation high-tech map project. HIL was featured as one of the Israeli startup …
Continue reading »HIL at JP Morgan Healthcare Conference – the CICC Israel Lounge HIL will partake in the CICC’s Israel Lounge, on January 13-14th, during the JP Morgan Healthcare conference. Come and meet 1×1 with our CEO Sagi Brink-Danan, to get the latest …
Continue reading »HIL awarded €2.5M in grant funding by the EU The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation – today approved HIL’s Phase-II proposal, at a total budget of €3.3M. The positive funding decision, …
Continue reading »Dr. Raphael Pfeffer, Assuta Chief Of Oncology and HIL Advisory Board Member, in an interview on the future of radiation therapy For its Medicine 2020 special issue The Marker Magazine featured an interview with Dr. Raphael (Raphi) Pfeffer, HIL’s advisory …
Continue reading »Dr. Ehud (Udi) Netzer joins HIL’s Board of Directors Dr. Netzer is a seasoned technology leader with over 35 years of experience covering all phases of basic research, product development, engineering, commercialization and senior management. During the past 15 years …
Continue reading »HIL and CERN announce collaboration (and Globes coverage) Novel technologies developed at CERN could be used in HIL’s system, helping to further reduce the size and cost of Proton Therapy systems and achieve HIL’s goal of making this important treatment …
Continue reading »HIL and Hebrew University announce new R&D and manufacturing facility in Jerusalem Calcalist, one of Israel’s leading financial news outlets, published HIL’s plan to set up a new R&D and manufacturing center on a 700 square-meter space leased from the …
Continue reading »HIL recognized in Israel’s Personal Medicine / Longevity industry 2019 report HIL is featured as one of 160 companies in the Aging Analytics Agency and Vetek association’s 2019 report on the Longevity Industry in Israel. The report is part of …
Continue reading »